Impel NeuroPharma Garners $12,000,000 Series B Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=07f5baca-7f3c-4075-a2f5-2480a4303165
Date
10/15/2015
Company Name
Impel NeuroPharma
Mailing Address
915 East Pine Street Seattle, WA 98122 USA
Company Description
Impel NeuroPharma was founded with a mission to enable drugs to bypass the blood brain barrier. Co-founders Rodney Ho, Ph.D., John Hoekman, Ph.D., and Michael Hite began their work together in 2008 at the University of Washington, and developed a technical concept into an enabling, commercializable technology.
Website
http://www.impelneuropharma.com
Transaction Type
Venture Equity
Transaction Amount
$12,000,000
Transaction Round
Series B
Proceeds Purposes
The company intends to use the funds to commercialize its technology.
M&A Terms
Venture Investor
3M Corporation
Venture Investor
Undisclosed